Clinical Trial Update: GVM±R in Patients With Relapsed or Refractory Aggressive NHL. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for GVM±R in adults with relapsed or refractory aggressive non-Hodgkin lymphoma, including Peripheral T-cell lymphoma and diffuse …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Peripheral T-cell Lymphoma

Drugs mentioned

• GVM±R

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Peripheral T Cell Lymphoma, Diffuse Large B-cell Lymphoma | Phase 2 | Status: RECRUITING